Αναζήτηση

σε πρόσθεσε στο Health

2026-07-01 11:31:47 -

Chitosan Hemostatic Powder Market Regulatory Framework and Safety Profile

The regulatory landscape for chitosan hemostatic powders has evolved to accommodate these medical devices within established frameworks for wound care and surgical hemostasis, with clear pathways for market access that vary by intended use and risk classification. The U.S. Food and Drug Administration regulates chitosan hemostatic powders as Class II medical devices under 21 CFR 878.4490...

0 Σχόλια 0 Μοιράστηκε 91 Views 0 Προεπισκόπηση